Safety and efficacy of irinotecan, oxaliplatin, and capecitabine (XELOXIRI) regimen with or without targeted drugs in patients with metastatic colorectal cancer: a retrospective cohort study

BACKGROUND: Five-fluorouracil, folinic acid, oxaliplatin and irinotecan (FOLFOXIRI) regimen is used as the first-line treatment for metastatic colorectal cancer (mCRC). The use of capecitabine, an oral fluoropyrimidine pro-drug, is feasible and safe; hence, it provides an interesting alternative to...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Xiu, Ou, Kai, Ma, Xiaoting, Gao, Lizhen, Wang, Qi, Zhang, Haizeng, Yang, Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9306070/
https://www.ncbi.nlm.nih.gov/pubmed/35864467
http://dx.doi.org/10.1186/s12885-022-09889-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9306070/
https://www.ncbi.nlm.nih.gov/pubmed/35864467
http://dx.doi.org/10.1186/s12885-022-09889-3

Ejemplares similares